Skip to main content

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Dec. 19, 2014, 71 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $119.85 to $228,846,700.60.

Highlighted Stocks Traded by Insiders:

Cell Therapeutics (CTIC) - FREE Research Report

Bianco James A, who is President and CEO at Cell Therapeutics, sold 40,000 shares at $2.44 on Dec. 19, 2014. Following this transaction, the President and CEO owned 1.9 million shares meaning that the stake was reduced by 2.05% with the 40,000-share transaction.

The shares most recently traded at $3.01, up $0.57, or 18.98% since the insider transaction. Historical insider transactions for Cell Therapeutics go as follows:

  • 4-Week # shares sold: 22,000
  • 12-Week # shares sold: 56,000
  • 24-Week # shares sold: 713,004

The average volume for Cell Therapeutics has been 3.7 million shares per day over the past 30 days. Cell Therapeutics has a market cap of $440.5 million and is part of the health care sector and drugs industry. Shares are up 53.93% year-to-date as of the close of trading on Tuesday.

CTI BioPharma Corp., a biopharmaceutical company, is engaged in the acquisition, development, and commercialization of treatments for cancer.

Exclusive Offer: Get the latest Stock Analysis on CTIC - FREE

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

FXCM (FXCM) - FREE Research Report

Romersa Michael, who is 10% Owner at FXCM, sold 62,301 shares at $16.96 on Dec. 19, 2014. Following this transaction, the 10% Owner owned 537,699 shares meaning that the stake was reduced by 10.38% with the 62,301-share transaction.

The shares most recently traded at $16.97, up $0.01, or 0.06% since the insider transaction. Historical insider transactions for FXCM go as follows:

TheStreet Recommends

  • 4-Week # shares bought: 7,500
  • 4-Week # shares sold: 93,744
  • 12-Week # shares bought: 7,500
  • 12-Week # shares sold: 393,744
  • 24-Week # shares bought: 7,500
  • 24-Week # shares sold: 393,744

The average volume for FXCM has been 514,900 shares per day over the past 30 days. FXCM has a market cap of $799.8 million and is part of the financial sector and financial services industry. Shares are down 4.2% year-to-date as of the close of trading on Thursday.

FXCM Inc., through its subsidiaries, provides online foreign exchange (FX) trading and related services to retail and institutional customers worldwide. It operates in two segments, Retail Trading and Institutional Trading. The stock currently has a dividend yield of 1.42%. The company has a P/E ratio of 169.6. Currently, there are 4 analysts who rate FXCM a buy, 1 analyst rates it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on FXCM - FREE

TheStreet Quant Ratings

rates FXCM as a

hold

. The company's strengths can be seen in multiple areas, such as its revenue growth, increase in net income and growth in earnings per share. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity, poor profit margins and weak operating cash flow. Get the full

FXCM Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Salesforce.com (CRM) - FREE Research Report

Benioff Marc, who is Chairman of the Board & CEO at Salesforce.com, sold 25,000 shares at $59.58 on Dec. 19, 2014. Following this transaction, the Chairman of the Board & CEO owned 38.8 million shares meaning that the stake was reduced by 0.06% with the 25,000-share transaction.

The shares most recently traded at $59.86, up $0.28, or 0.47% since the insider transaction. Historical insider transactions for Salesforce.com go as follows:

  • 4-Week # shares sold: 225,165
  • 12-Week # shares sold: 836,165
  • 24-Week # shares sold: 1.7 million

The average volume for Salesforce.com has been 4.8 million shares per day over the past 30 days. Salesforce.com has a market cap of $36.0 billion and is part of the technology sector and computer software & services industry. Shares are up 3.28% year-to-date as of the close of trading on Thursday.

salesforce.com, inc. provides enterprise cloud computing solutions to various businesses and industries worldwide. Currently, there are 23 analysts who rate Salesforce.com a buy, 1 analyst rates it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CRM - FREE

TheStreet Quant Ratings

rates Salesforce.com as a

hold

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, increase in stock price during the past year and growth in earnings per share. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity, weak operating cash flow and generally higher debt management risk. Get the full

Salesforce.com Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null